News Home

How Will the Market React to Kaleido Biosciences Inc (KLDO) Stock Getting a Bearish Rating

Thursday, April 15, 2021 01:15 PM | InvestorsObserver Analysts
How Will the Market React to Kaleido Biosciences Inc (KLDO) Stock Getting a Bearish Rating

Overall market sentiment has been down on Kaleido Biosciences Inc (KLDO) stock lately. KLDO receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Kaleido Biosciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on KLDO!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With KLDO Stock Today?

Kaleido Biosciences Inc (KLDO) stock is trading at $8.20 as of 1:14 PM on Thursday, Apr 15, an increase of $1.33, or 19.36% from the previous closing price of $6.87. The stock has traded between $6.92 and $8.40 so far today. Volume today is above average. So far 448,208 shares have traded compared to average volume of 283,324 shares.

To see InvestorsObserver's Sentiment Score for Kaleido Biosciences Inc click here.

More About Kaleido Biosciences Inc

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Click Here to get the full Stock Score Report on Kaleido Biosciences Inc (KLDO) Stock.

You May Also Like